2,3,4,5-Tetrahydro-7-methoxy-4-(methyl-d3)-

2,3,4,5-Tetrahydro-7-methoxy-4-(methyl-d3)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

t is a labelled benzothiazepine derivative that binds the RyR1 channel and enhances the binding affinity of Calstabin-1. By preventing the depletion of Calstabin-1 from the RyR1 complex, S 107 slows muscle fatique and reduces muscle damage in exercised mice. In a murine model of Duchenne muscular dystrophy, S 107 reduces biochemical and histological evidence of the muscle damage associated with muscular dystrophy, improves muscle function, and increases exercise performance.

2,3,4,5-Tetrahydro-7-methoxy-4-(methyl-d3)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2,3,4,5-Tetrahydro-7-methoxy-4-(methyl-d3)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Chemsky (shanghai) International Co.,Ltd	021-50135380	shchemsky@sina.com	China	15421	60
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 13028896684	sales@rrkchem.com	China	56057	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44843	58

---

• 2,3,4,5-Tetrahydro-7-methoxy-4-(methyl-d3)-
• 2,3,4,5-Tetrahydro-7-methoxy-4-(methyl-d3)-1,4-benzothiazepine
• 7-methoxy-4-(trideuteriomethyl)-3,5-dihydro-2H-1,4-benzothiazepine
• 1167435-22-4
• C11H12D3NOS
• Aromatics
• Heterocycles
• Intermediates & Fine Chemicals
• Isotope Labelled Compounds
• Pharmaceuticals
• Sulfur & Selenium Compounds